The genes we’re dealt
By Erik Parens,
Aeon
| 11. 10. 2020
Over the past decade, economists, sociologists and psychologists have begun collaborating with geneticists to investigate how genomic differences among human beings are linked to differences in their behaviours and social outcomes. The insights sought are wide-ranging: why do some of us have a greater sense of subjective wellbeing than others? Why do some go further in school than others? When it comes to income, why do some people earn more and others less?
As surprising as it might be to readers familiar with the history of often-ugly efforts to investigate complex behaviours and outcomes through genetics, some prominent members of this new cohort of researchers are optimistic that their work will advance progressive political agendas. According to the progressive authors of a recent European Commission report, insights from what I call ‘social genomics’ are ‘fully compatible with agendas that aim to combat inequalities and that embrace diversity.’
Indeed, findings from social genomics are compatible with what we in the United States consider Left-leaning agendas to combat inequalities. They are, however, equally compatible with what we think of as Right-leaning...
Related Articles
By Megan Molteni and Anil Oza, STAT | 10.07.2025
For two years, a panel of scientific experts, clinicians, and patient advocates had been hammering out ways to increase community engagement in National Institutes of Health-funded science. When they presented their road map to the NIH Director Jay Bhattacharya last...
Paula Amato & Shoukhrat Mitalipov
[OHSU News/Christine Torres Hicks]
On September 30th, a team of 21 scientists from Oregon Health & Science University (OHSU) published a significant paper in Nature Communications, with a scientifically accurate but, to many, somewhat abstruse headline:
Induction of experimental cell division to generate cells with reduced chromosome ploidy
The lead authors were Shoukhrat Mitalipov, recently described here as “a push-the-envelope biologist,” and his long-term colleague Paula Amato. (Recall that in July the pair had co-published with...
By Pam Belluck, The New York Times | 10.17.2025
Before dawn on a March morning, Doug Whitney walked into a medical center 2,000 miles from home, about to transform from a mild-mannered, bespectacled retiree into a superhuman research subject.
First, a doctor inserted a needle into his back to...
By Julia Black, MIT Technology Review | 10.16.2025
Consider, if you will, the translucent blob in the eye of a microscope: a human blastocyst, the biological specimen that emerges just five days or so after a fateful encounter between egg and sperm. This bundle of cells, about the size of...